Skip to content
L111L111L111

Drawing based on the label description. No photo yet.

“1000 mg, yellow to dark yellow, biconvex, oval shaped, film coated tablets, "L111" debossed on one side and plain on other side without any layer separation”

L111 pill

Pill with imprint L111 is yellow, oval, 20 mm and has been identified as Dapagliflozin and Metformin Hydrochloride 10 mg / 1000 mg. It is used for type 2 diabetes and heart failure. It is supplied by Lupin Pharmaceuticals, Inc.

Dapagliflozin and Metformin Hydrochloride 10 mg / 1000 mg

Imprint
L111
Strength
Dapagliflozin 10 mg / Metformin Hydrochloride 1000 mg
Used for
Type 2 diabetes and heart failure
Color
Yellow
Shape
Oval
Size
20 mm
Score
No score line
Form
Tablet, extended release
Manufacturer
Lupin Pharmaceuticals, Inc
Drug class
Diabetes medicine (SGLT2 inhibitor)
NDC
70748-104, 70748-104-06

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Dapagliflozin and Metformin pills and guides

What is Dapagliflozin and Metformin used for?

Dapagliflozin and Metformin is used for type 2 diabetes and heart failure.

Medicine type
Diabetes medicine (SGLT2 inhibitor); diabetes medicine (biguanide)
Official uses from the US prescribing label

Dapagliflozin and metformin hydrochloride extended-release tablets are a combination of dapagliflozin and metformin hydrochloride (HCl) extended-release, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Dapagliflozin, when used as a component of dapagliflozin and metformin hydrochloride extended-release tablets, is indicated in adults with type 2 diabetes mellitus to reduce the risk of:

  • Sustained eGFR decline, end-stage kidney disease, cardiovascular (CV) death, and hospitalization for heart failure in patients with chronic kidney disease at risk of progression.
  • CV death, hospitalization for heart failure, and urgent heart failure visit in patients with heart failure.
  • Hospitalization for heart failure in patients with type 2 diabetes mellitus and either established CV disease or multiple CV risk factors.

Limitations of Use

  • Dapagliflozin and metformin hydrochloride extended-release tablets are not recommended for use to improve glycemic control in patients with type 1 diabetes mellitus.
  • Because of the metformin hydrochloride component, the use of dapagliflozin and metformin hydrochloride extended-release tablets is limited to patients with type 2 diabetes mellitus for all indications.
  • Dapagliflozin and metformin hydrochloride extended-release tablets are not recommended for the treatment of chronic kidney disease in patients with polycystic kidney disease or patients requiring or with a recent history of immunosuppressive therapy for kidney disease. Dapagliflozin and metformin hydrochloride extended-release tablets are not expected to be effective in these populations.

Pediatric use information is approved for AstraZeneca AB’s Xigduo ® XR (dapagliflozin and metformin hydrochloride) Extended-Release Tablets. However, due to AstraZeneca AB’s marketing exclusivity rights, this drug product is not labeled with that information.

From the FDA-approved label on DailyMed (published Sep 24, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows L111 and the other side is plain.
  • It is yellow, oval, 20 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Dapagliflozin, Metformin Hydrochloride

Inactive: Crospovidone, Silicon Dioxide, Hypromelloses, Lactose Monohydrate, Microcrystalline Cellulose, Magnesium Stearate, Povidone, Carboxymethylcellulose Sodium, Sodium Stearyl Fumarate, Polyvinyl Alcohol, Unspecified, Polyethylene Glycol, Unspecified, Talc, Titanium Dioxide, D&c Yellow No. 10, Fd&c Yellow No. 6, Fd&c Blue No. 2

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Dapagliflozin and Metformin pills